Announced Mon, 13 Jul · 20:57 IST
Arbitration against Optimus Drugs settled mutually, no penalty to company
Regulatory & Legal View source PDF
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹383.00
prior close
₹381.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.4—-0.7-2.6-2.8-4.1-5.2-4.3-6.2————
Up moveDown movePending
AI summary
Gujarat Themis Biosyn had initiated arbitration against Optimus Drugs Private Limited over a commercial dispute, as disclosed on 26 June 2026. The company has now informed exchanges that both parties have amicably resolved the matter and will settle it mutually, and the arbitration will be disposed of accordingly. The company will not pay any penalty due to the settlement and there will be no material financial impact.
Likely market impact
Neutral to mildly positive. The dispute is resolved without penalty or material financial hit, removing overhang and uncertainty for shareholders.